Overview

Orqis^® Medical Corporation is a privately held medical device company in Orange County, California.  Orqis develops and sells minimally invasive devices that improve cardiac performance through aortic flow therapy. Orqis devices uniquely bridge the treatment gap between medical management and more invasive procedures without ever touching the heart.

Orqis Medical developed continuous aortic flow augmentation (CAFA) as a platform technology to assist the heart’s ability to pump blood.  By augmenting natural blood flow with continuous blood flow in the descending aorta, CAFA changes blood flow dynamics to improve cardiac performance in heart failure patients.  

The percutaneous Cancion^® System is commercially available in select markets outside the United States. The implantable  Exeleras^® System, is currently in development.

The company's novel and proprietary therapeutic devices, and treatment methods, are protected by 14 issued U.S. patents, incorporating over 285 separate claims, and several issued international patents. Orqis^® Medical Corporation was founded in 1997.

Orqis Medical: At a Glance:

• Founded: 1997
• Location: Lake Forest, California
• Therapeutic Focus: Heart Failure
• Products:
  • Cancion System: Commercialized in select geographies outside the U.S.
  • Exeleras System: In development
• IP Position: 14 issued U.S. patents covering over 285 claims